STRATEC SE (Frankfurt: SBS; Prime Standard) held its Annual General Meeting on June 23, 2026, where shareholders approved all agenda items with clear majorities. The company will distribute a dividend of EUR 0.60 per share for the 2024 financial year, unchanged from the previous year. The total dividend payout amounts to EUR 7.3 million, payable on June 26, 2026, via depositing banks.
In addition to the dividend, shareholders ratified the actions of the Board of Management and the Supervisory Board and elected PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft (PwC), Frankfurt am Main, as auditor for the 2026 financial year. The remuneration report was also approved. The meeting saw 70.1 percent of the registered share capital represented.
This approval underscores shareholder confidence in STRATEC's strategic direction and financial stability. The consistent dividend reflects the company's commitment to rewarding investors while maintaining capital for growth. STRATEC designs and manufactures automated analyzer systems and consumables for clinical diagnostics and life sciences, covering the entire value chain from development to production.
Detailed voting results and further information are available at www.stratec.com/agm. The company's shares are traded in the Prime Standard segment of the Frankfurt Stock Exchange under ISIN DE000STRA555.
This meeting marks a pivotal moment for STRATEC as it continues to navigate the evolving diagnostics market. The approval of all resolutions suggests strong alignment between management and shareholders, which is crucial for long-term value creation. With a solid dividend policy and clear strategic focus, STRATEC remains well-positioned to capitalize on opportunities in the life sciences sector.
